OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lipid nanoparticles for siRNA delivery in cancer treatment
Souhaila H. El Moukhtari, Elisa Garbayo, Ane Amundarain, et al.
Journal of Controlled Release (2023) Vol. 361, pp. 130-146
Closed Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Bilan Wang, Shiqi Hu, Yan Teng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 79

Nanoparticles for efficient drug delivery and drug resistance in glioma: New perspectives
Jiyuan Liu, Fan Yang, Jinqu Hu, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 5
Open Access | Times Cited: 11

Advances in Microfluidic‐Based Core@Shell Nanoparticles Fabrication for Cancer Applications
Duarte Almeida, João Ferreira Gil, Antonio José Guillot, et al.
Advanced Healthcare Materials (2024)
Open Access | Times Cited: 9

Exosomal lncRNAs as diagnostic and therapeutic targets in multiple myeloma
Hong Yan, Nan Jiang, M Kellis, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access | Times Cited: 1

Targeted delivery systems of siRNA based on ionizable lipid nanoparticles and cationic polymer vectors
Zhao Yao, Taiqing Liu, Jingwen Wang, et al.
Biotechnology Advances (2025) Vol. 81, pp. 108546-108546
Closed Access | Times Cited: 1

Advancing gastric cancer treatment: nanotechnology innovations and future prospects
Tengfei Yang, Lin Guo
Cell Biology and Toxicology (2024) Vol. 40, Iss. 1
Open Access | Times Cited: 7

The Application of Biomaterials for the Vaccine, Treatment, and Detection of SARS-CoV-2
Yuan Hu, Lili Liu, Shenghua Zhang, et al.
ACS Omega (2024) Vol. 9, Iss. 5, pp. 5175-5192
Open Access | Times Cited: 6

Emerging advances in delivery systems for mRNA cancer vaccines
Zhimei Jiang, Yanhua Xu, Guangsheng Du, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 287-301
Closed Access | Times Cited: 5

Recent advanced lipid-based nanomedicines for overcoming cancer resistance
Piroonrat Dechbumroong, Runjing Hu, Wisawat Keaswejjareansuk, et al.
Cancer Drug Resistance (2024)
Open Access | Times Cited: 5

Nucleic Acid Armor: Fortifying RNA Therapeutics through Delivery and Targeting Innovations for Immunotherapy
Yi Jiang, Bolong Jiang, Zhenru Wang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8888-8888
Open Access | Times Cited: 5

Ether bond-modified lipid nanoparticles for enhancing the treatment effect of hepatic fibrosis
Runxuan Chu, Jianglong Kong, Qiang Gao, et al.
International Journal of Pharmaceutics (2025) Vol. 671, pp. 125192-125192
Closed Access

Nanotecnologia em sistemas de entrega de fármacos: avanços recentes e aplicações futuras
Christiane Silva da Costa, Marilia Danyelle Nunes Rodruigues, Ana Paula Santos, et al.
Contribuciones a las Ciencias Sociales (2025) Vol. 18, Iss. 1, pp. e14646-e14646
Closed Access

Lipid Nanoparticles and Skin: Discoveries and Advances
Debora Santonocito, Carmelo Puglia
Cosmetics (2025) Vol. 12, Iss. 1, pp. 22-22
Open Access

NANOTECHNOLOGY-DRIVEN THERAPEUTICS FOR LIVER CANCER: CLINICAL APPLICATIONS AND PHARMACEUTICAL INSIGHTS
Lokeshvar Ravikumar, RAMAIYAN VELMURUGAN, Nithin Vidiyala, et al.
Asian Journal of Pharmaceutical and Clinical Research (2025), pp. 8-26
Open Access

Nanoparticle troopers: Infiltrating cancer cells for targeted therapies
Shivam Rajput, Rishabha Malviya, Sankha Bhattacharya, et al.
Nano-Structures & Nano-Objects (2025) Vol. 41, pp. 101453-101453
Closed Access

Reticuloendothelial system blockade does not enhance siRNA-LNP circulation or tumor accumulation in mice
Pol Escudé Martinez de Castilla, Mariona Estapé Sentí, Sandra Erkens, et al.
International Journal of Pharmaceutics X (2025) Vol. 9, pp. 100324-100324
Open Access

siRNA-based Delivery Systems: Technologies, Carriers, Applications, and Approved Products
Parisa Ghasemiyeh, Soliman Mohammadi‐Samani
European Journal of Pharmacology (2025), pp. 177441-177441
Closed Access

Landscape of small nucleic acid therapeutics: moving from the bench to the clinic as next-generation medicines
Mohan Liu, Yusi Wang, Yi-Bing Zhang, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access

Functionalized Nanomaterials in Cancer Treatment: A Review
Óscar Gutiérrez Coronado, Cuauhtémoc Sandoval‐Salazar, José Luis Muñoz‐Carrillo, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2633-2633
Open Access

Smart Delivery Vehicles for Cancer: Categories, Unique Roles and Therapeutic Strategies
Yiyu Zeng, Yijun Gao, Liming He, et al.
Nanoscale Advances (2024) Vol. 6, Iss. 17, pp. 4275-4308
Open Access | Times Cited: 4

Understanding nanoparticle-liver interactions in nanomedicine
Yuxin He, Yifan Wang, Lin Wang, et al.
Expert Opinion on Drug Delivery (2024) Vol. 21, Iss. 6, pp. 829-843
Closed Access | Times Cited: 4

Novel Modifications and Delivery Modes of Cyclic Dinucleotides for STING Activation in Cancer Treatment
Yanjun Lu, Zhiyan Li, Xudong Zhu, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 181-197
Open Access

Page 1 - Next Page

Scroll to top